Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Rebuilds R&D Amid Growing Near-Term Pressures

Jun 01 2011

Related Content

U.K's Heptares Signs Up AstraZeneca In Latest GPCR-Focused Discovery Pact

May 31 2011

Pfizer's Global R&D Network: Rapid Integration Means Doing More With Less

Nov 11 2009

R&D Swapping: AstraZeneca Lures Mackay From Pfizer To Head Global R&D

May 26 2010

Putting The Pieces Together Again: GSK Creates End-To-End Business Units

Jan 01 2011

A Look Back At 2010: In Search Of New Biopharma Models

Jan 01 2011

Brilinta "Complete Response" Letter Suggests FDA Unswayed On U.S. Efficacy

Dec 17 2010

Related Companies

AstraZeneca PLC

Pfizer Inc.

Bristol Myers Squibb Company

Merck & Co., Inc.

MedImmune LLC

GSK plc

Eli Lilly and Company

Eli Lilly and Company

Bristol Myers Squibb Company

Roche Holding AG

Anthem Inc.

Nektar Therapeutics

Astellas Pharma, Inc.

Bayer AG

Bayer AG

Galderma S.A.

Novartis AG

Nxera Pharma Co., Ltd.

Additional Topics

BioPharmaceutical

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window